Genetron, a Beijing-based cancer genomics firm, plans to raise up to $175.5 million by offering 13 million American depositary shares (ADS) in an initial public offering on the Nasdaq, according to its amended filing.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
